본문 바로가기
KERD
논문KCI 등재

Update on the Epidemiology, Pathogenesis, and Biomarkers of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy

최재철|Yumi Yamamoto|Yi-Chu Liao|Yi-Chung Lee|Masafumi Ihara
대한신경과학회 (Korean Neurological Association)|2023.01|Journal of Clinical Neurology|제19권 제1호|pp. 12-27

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

biomarkermagnetic resonance imagingCADASILNOTCH3 mutation

초록

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common monogenic disorder of the cerebral small blood vessels. It is caused by mutations in the NOTCH3 gene on chromosome 19, and more than 280 distinct pathogenic mutations have been reported to date. CADASIL was once considered a very rare disease with an estimated prevalence of 1.3–4.1 per 100,000 adults. However, recent large-scale genomic studies have revealed a high prevalence of pathogenic NOTCH3 variants among the general population, with the highest risk being among Asians. The disease severity and age at onset vary significantly even among individuals who carry the same NOTCH3 mutations. It is still unclear whether a significant genotype–phenotype correlation is present in CADASIL. The accumulation of granular osmiophilic material in the vasculature is a characteristic feature of CADASIL. However, the exact pathogenesis of CADASIL remains largely unclear despite various laboratory and clinical observations being made. Major hypotheses proposed so far have included aberrant NOTCH3 signaling, toxic aggregation, and abnormal matrisomes. Several characteristic features have been observed in the brain magnetic resonance images of patients with CADASIL, including subcortical lacunar lesions and white matter hyperintensities in the anterior temporal lobe or external capsule, which were useful in differentiating CADASIL from sporadic stroke in patients. The number of lacunes and the degree of brain atrophy were useful in predicting the clinical outcomes of patients with CADASIL. Several promising blood biomarkers have also recently been discovered for CADASIL, which require further research for validation.

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common monogenic disorder of the cerebral small blood vessels. It is caused by mutations in the NOTCH3 gene on chromosome 19, and more than 280 distinct pathogenic mutations have been reported to date. CADASIL was once considered a very rare disease with an estimated prevalence of 1.3–4.1 per 100,000 adults. However, recent large-scale genomic studies have revealed a high prevalence of pathogenic NOTCH3 variants among the general population, with the highest risk being among Asians. The disease severity and age at onset vary significantly even among individuals who carry the same NOTCH3 mutations. It is still unclear whether a significant genotype–phenotype correlation is present in CADASIL. The accumulation of granular osmiophilic material in the vasculature is a characteristic feature of CADASIL. However, the exact pathogenesis of CADASIL remains largely unclear despite various laboratory and clinical observations being made. Major hypotheses proposed so far have included aberrant NOTCH3 signaling, toxic aggregation, and abnormal matrisomes. Several characteristic features have been observed in the brain magnetic resonance images of patients with CADASIL, including subcortical lacunar lesions and white matter hyperintensities in the anterior temporal lobe or external capsule, which were useful in differentiating CADASIL from sporadic stroke in patients. The number of lacunes and the degree of brain atrophy were useful in predicting the clinical outcomes of patients with CADASIL. Several promising blood biomarkers have also recently been discovered for CADASIL, which require further research for validation.

참고문헌 (144)

  1. Jay Chol Choi, "Genetics of Cerebral Small Vessel Disease", 대한뇌졸중영문학회지, 17(1), pp.7~16 (2015), 대한뇌졸중학회
  2. 최재철, "Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: A Genetic Cause of Cerebral Small Vessel Disease", Journal of Clinical Neurology, 6(1), pp.1~9 (2010), 대한신경과학회
  3. Chabriat H, "Cadasil", Lancet Neurol, 8, pp.643~653 (2009)
  4. Tikka S, "Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients", Brain, 132(Pt 4), pp.933~939 (2009)
  5. Joutel A, "Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia", Nature, 383, pp.707~710 (1996)
  6. Joutel A, "Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients", Lancet, 350, pp.1511~1515 (1997)
  7. Ishiko A, "Notch3 ectodomain is a major component of granular osmiophilic material(GOM)in CADASIL", Acta Neuropathol, 112, pp.333~339 (2006)
  8. Joutel A, "Perturbations of the cerebrovascular matrisome : a convergent mechanism in small vessel disease of the brain?", J Cereb Blood Flow Metab, 36, pp.143~157 (2016)
  9. Razvi SS, "The prevalence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy(CADASIL)in the west of Scotland", J Neurol Neurosurg Psychiatry, 76, pp.739~741 (2005)
  10. Bianchi S, "CADASIL in central Italy : a retrospective clinical and genetic study in 229 patients", J Neurol, 262, pp.134~141 (2015)
  11. Moreton FC, "Changing clinical patterns and increasing prevalence in CADASIL", Acta Neurol Scand, 130, pp.197~203 (2014)
  12. Narayan SK, "The minimum prevalence of CADASIL in northeast England", Neurology, 78, pp.1025~1027 (2012)
  13. Rutten JW, "Archetypal NOTCH3 mutations frequent in public exome : implications for CADASIL", Ann Clin Transl Neurol, 3, pp.844~853 (2016)
  14. Grami N, "Global assessment of Mendelian stroke genetic prevalence in 101 635 individuals from 7 ethnic groups", Stroke, 51, pp.1290~1293 (2020)
  15. Choi JC, "Intracerebral hemorrhages in CADASIL", Neurology, 67, pp.2042~2044 (2006)
  16. Liao YC, "Characterization of CADASIL among the Han Chinese in Taiwan : distinct genotypic and phenotypic profiles", PLoS One, 10, pp.e0136501~ (2015)
  17. Dichgans M, "The phenotypic spectrum of CADASIL : clinical findings in 102 cases", Ann Neurol, 44, pp.731~739 (1998)
  18. Liem MK, "Lacunar infarcts are the main correlate with cognitive dysfunction in CADASIL", Stroke, 38, pp.923~928 (2007)
  19. O’Sullivan M, "MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL", Neurology, 56, pp.628~634 (2001)
  20. Chabriat H, "Predictors of clinical worsening in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy : prospective cohort study", Stroke, 47, pp.4~11 (2016)
  21. Jickling GC, "Biomarker panels in ischemic stroke", Stroke, 46, pp.915~920 (2015)
  22. Vilar-Bergua A, "Blood and CSF biomarkers in brain subcortical ischemic vascular disease : involved pathways and clinical applicability", J Cereb Blood Flow Metab, 36, pp.55~71 (2016)
  23. Gravesteijn G, "Serum neurofilament light correlates with CADASIL disease severity and survival", Ann Clin Transl Neurol, 6, pp.46~56 (2019)
  24. Primo V, "Blood biomarkers in a mouse model of CADASIL", Brain Res, 1644, pp.118~126 (2016)
  25. Sonninen V, "Hereditary multi-infarct dementia", Eur Neurol, 27, pp.209~215 (1987)
  26. Stevens DL, "Chronic familial vascular encephalopathy", Lancet, 1, pp.1364~1365 (1977)
  27. Tournier-Lasserve E, "Autosomal dominant syndrome with strokelike episodes and leukoencephalopathy", Stroke, 22, pp.1297~1302 (1991)
  28. Baudrimont M, "Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study", Stroke, 24, pp.122~125 (1993)
  29. Ducros A, "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, genetic homogeneity, and mapping of the locus within a 2-cM interval", Am J Hum Genet, 58, pp.171~181 (1996)
  30. Mizuno T, "Clinical and genetic aspects of CADASIL", Front Aging Neurosci, 12, pp.91~ (2020)
  31. Muiño E, "Systematic review of cysteine-sparing NOTCH3 missense mutations in patients with clinical suspicion of CADASIL", Int J Mol Sci, 18, pp.1964~ (2017)
  32. Moccia M, "Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features", Neurobiol Aging, 36, pp.547~ (2015)
  33. Pippucci T, "Homozygous NOTCH3 null mutation and impaired NOTCH3signaling in recessive early-onset arteriopathy and cavitating leukoencephalopathy", EMBO Mol Med, 7, pp.848~858 (2015)
  34. Ruchoux MM, "CADASIL : cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy", J Neuropathol Exp Neurol, 56, pp.947~964 (1997)
  35. Joutel A, "Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis", Lancet, 358, pp.2049~2051 (2001)
  36. Cho BPH, "NOTCH3 variants are more common than expected in the general population and associated with stroke and vascular dementia : an analysis of 200, 000 participants", J Neurol Neurosurg Psychiatry, 92, pp.694~701 (2021)
  37. Hack RJ, "Cysteine-altering NOTCH3 variants are a risk factor for stroke in the elderly population", Stroke, 51, pp.3562~3569 (2020)
  38. Lee YC, "NOTCH3 cysteine-altering variant is an important risk factor for stroke in the Taiwanese population", Neurology, 94, pp.e87~e96 (2020)
  39. Kang CH, "Pathogenic NOTCH3 variants are frequent among the Korean general population", Neurol Genet, 7, pp.e639~ (2021)
  40. Tang SC, "Prevalence and clinical characteristics of stroke patients with p. R544C NOTCH3 mutation in Taiwan", Ann Clin Transl Neurol, 6, pp.121~128 (2018)
  41. Okada T, "Prevalence and atypical clinical characteristics of NOTCH3 mutations among patients admitted for acute lacunar infarctions", Front Aging Neurosci, 12, pp.130~ (2020)
  42. Choi JC, "Screening for NOTCH3 gene mutations among 151 consecutive Korean patients with acute ischemic stroke", J Stroke Cerebrovasc Dis, 22, pp.608~614 (2013)
  43. Kilarski LL, "Prevalence of CADASIL and Fabry disease in a cohort of MRI defined younger onset lacunar stroke", PLoS One, 10, pp.e0136352~ (2015)
  44. Markus HS, "Diagnostic strategies in CADASIL", Neurology, 59, pp.1134~1138 (2002)
  45. Opherk C, "Long-term prognosis and causes of death in CADASIL : a retrospective study in 411 patients", Brain, 127(Pt 11), pp.2533~2539 (2004)
  46. Oberstein SA, "Diagnostic strategies in CADASIL", Neurology, 60, pp.2020~ (2003)
  47. Ueda A, "Genotypic and phenotypic spectrum of CADASIL in Japan : the experience at a referral center in Kumamoto University from 1997 to 2014", J Neurol, 262, pp.1828~1836 (2015)
  48. Chen S, "Clinical features and mutation spectrum in Chinese patients with CADASIL : a multicenter retrospective study", CNS Neurosci Ther, 23, pp.707~716 (2017)
  49. Choi JC, "Diversity of stroke presentation in CADASIL : study from patients harboring the predominant NOTCH3 mutation R544C", J Stroke Cerebrovasc Dis, 22, pp.126~131 (2013)
  50. Mukai M, "A Japanese CADASIL patient with homozygous NOTCH3 p. Arg-544Cys mutation confirmed pathologically", J Neurol Sci, 394, pp.38~40 (2018)
  51. Soong BW, "A homozygous NOTCH3 mutation p. R544C and a heterozygous TREX1variant p. C99MfsX3 in a family with hereditary small vessel disease of the brain", J Chin Med Assoc, 76, pp.319~324 (2013)
  52. Mykkänen K, "Detection of the founder effect in Finnish CADASIL families", Eur J Hum Genet, 12, pp.813~819 (2004)
  53. Kim YE, "Spectrum of NOTCH3 mutations in Korean patients with clinically suspicious cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy", Neurobiol Aging, 35, pp.726~ (2014)
  54. Shindo A, "A nationwide survey and multicenter registry-based database of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy in Japan", Front Aging Neurosci, 12, pp.216~ (2020)
  55. Hu Y, "NOTCH3 variants and genotype-phenotype features in Chinese CADASIL patients", Front Genet, 12, pp.705284~ (2021)
  56. Chabriat H, "Clinical spectrum of CADASIL : a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy", Lancet, 346, pp.934~939 (1995)
  57. Desmond DW, "The natural history of CADASIL : a pooled analysis of previously published cases", Stroke, 30, pp.1230~1233 (1999)
  58. Schon F, ""CADASIL coma" : an underdiagnosed acute encephalopathy", J Neurol Neurosurg Psychiatry, 74, pp.249~252 (2003)
  59. Drazyk AM, "Encephalopathy in a large cohort of British cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy patients", Stroke, 50, pp.283~290 (2019)
  60. Lee JS, "Cerebral microbleeds, hypertension, and intracerebral hemorrhage in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy", Front Neurol, 8, pp.203~ (2017)
  61. Liao YC, "Intracerebral hemorrhage in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy : prevalence, clinical and neuroimaging features and risk factors", Stroke, 52, pp.985~993 (2021)
  62. Puy L, "Cerebral microbleeds and the risk of incident ischemic stroke in CADASIL(cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy)", Stroke, 48, pp.2699~2703 (2017)
  63. Nannucci S, "Location, number and factors associated with cerebral microbleeds in an Italian-British cohort of CADASIL patients", PLoS One, 13, pp.e0190878~ (2018)
  64. Lesnik Oberstein SA, "Cerebral microbleeds in CADASIL", Neurology, 57, pp.1066~1070 (2001)
  65. Dichgans M, "Cerebral microbleeds in CADASIL : a gradient-echo magnetic resonance imaging and autopsy study", Stroke, 33, pp.67~71 (2002)
  66. Chung CP, "Cerebral microbleed burdens in specific brain regions are associated with disease severity of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy", J Am Heart Assoc, 9, pp.e016233~ (2020)
  67. Adib-Samii P, "Clinical spectrum of CADASIL and the effect of cardiovascular risk factors on phenotype : study in 200 consecutively recruited individuals", Stroke, 41, pp.630~634 (2010)
  68. Choi JC, "Headache among CADASIL patients with R544C mutation : prevalence, characteristics, and associations", Cephalalgia, 34, pp.22~28 (2014)
  69. Wang YF, "Mutation screening and association analysis of NOTCH3 p. R544C in patients with migraine with or without aura", Cephalalgia, 42, pp.888~898 (2022)
  70. Pescini F, "A pathogenic mutation on exon 21 of the NOTCH3 gene causing CADASIL in an octogenarian paucisymptomatic patient", J Neurol Sci, 267, pp.170~173 (2008)
  71. Lee YC, "The remarkably variable expressivity of CADASIL : report of a minimally symptomatic man at an advanced age", J Neurol, 256, pp.1026~1027 (2009)
  72. Rutten JW, "Broad phenotype of cysteine-altering NOTCH3 variants in UK Biobank : CADASIL to nonpenetrance", Neurology, 95, pp.e1835~e1843 (2020)
  73. Rutten JW, "The effect of NOTCH3 pathogenic variant position on CADASIL disease severity : NOTCH3 EGFr 1-6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7-34 pathogenic variant", Genet Med, 21, pp.676~682 (2019)
  74. Mukai M, "Genotype-phenotype correlations and effect of mutation location in Japanese CADASIL patients", J Hum Genet, 65, pp.637~646 (2020)
  75. Gravesteijn G, "NOTCH3 variant position is associated with NOTCH3 aggregation load in CADASIL vasculature", Neuropathol Appl Neurobiol, 48, pp.e12751~ (2022)
  76. Bellavia D, "Notch3 : from subtle structural differences to functional diversity", Oncogene, 27, pp.5092~5098 (2008)
  77. Logeat F, "The Notch1 receptor is cleaved constitutively by a furin-like convertase", Proc Natl Acad Sci U S A, 95, pp.8108~8112 (1998)
  78. Groot AJ, "Regulated proteolysis of NOTCH2 and NOTCH3 receptors by ADAM10 and presenilins", Mol Cell Biol, 34, pp.2822~2832 (2014)
  79. Hofmann JJ, "Notch signaling in blood vessels : who is talking to whom about what?", Circ Res, 100, pp.1556~1568 (2007)
  80. Joutel A, "Pathogenic mutations associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy differently affect Jagged1 binding and Notch3 activity via the RBP", JK signaling Pathway, 2004, pp.74, 338~347
  81. Peters N, "CADASIL-associated Notch3 mutations have differential effects both on ligand binding and ligand-induced Notch3 receptor signaling through RBP-Jk", Exp Cell Res, 299, pp.454~464 (2004)
  82. Haritunians T, "CADASIL Notch3 mutant proteins localize to the cell surface and bind ligand", Circ Res, 90, pp.506~508 (2002)
  83. Low WC, "CADASILcausing mutations do not alter Notch3 receptor processing and activation", Neuroreport, 17, pp.945~949 (2006)
  84. Karlström H, "A CADASIL-mutated Notch 3 receptor exhibits impaired intracellular trafficking and maturation but normal ligand-induced signaling", Proc Natl Acad Sci U S A, 99, pp.17119~17124 (2002)
  85. Haritunians T, "Functional analysis of a recurrent missense mutation in Notch3 in CADASIL", J Neurol Neurosurg Psychiatry, 76, pp.1242~1248 (2005)
  86. Fouillade C, "Activating NOTCH3 mutation in a patient with small-vessel-disease of the brain", Hum Mutat, 29, pp.452~ (2008)
  87. Opherk C, "CADASIL mutations enhance spontaneous multimerization of NOTCH3", Hum Mol Genet, 18, pp.2761~2767 (2009)
  88. Young KZ, "Oligomerization, trans-reduction, and instability of mutant NOTCH3in inherited vascular dementia", Commun Biol, 5, pp.331~ (2022)
  89. Duering M, "Co-aggregate formation of CADASIL-mutant NOTCH3 : a single-particle analysis", Hum Mol Genet, 20, pp.3256~3265 (2011)
  90. Meng H, "Biochemical characterization and cellular effects of CADASIL mutants of NOTCH3", PLoS One, 7, pp.e44964~ (2012)
  91. Takahashi K, "Mutations in NOTCH3 cause the formation and retention of aggregates in the endoplasmic reticulum, leading to impaired cell proliferation", Hum Mol Genet, 19, pp.79~89 (2010)
  92. Hanemaaijer ES, "Autophagy-lysosomal defect in human CADASIL vascular smooth muscle cells", Eur J Cell Biol, 97, pp.557~567 (2018)
  93. Neves KB, "ER stress and Rho kinase activation underlie the vasculopathy of CADASIL", JCI Insight, 4, pp.e131344~ (2019)
  94. Ruchoux MM, "Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy", Am J Pathol, 162, pp.329~342 (2003)
  95. Carare RO, "Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of vascular professional interest area (PIA): cerebrovascular disease and the failure of elimination of amyloid-β from the brain and retina with age and Alzheimer’s disease-opportunities for therapy", Alzheimers Dement(Amst), 12, pp.e12053~ (2020)
  96. Yamamoto Y, "Brain microvascular accumulation and distribution of the NOTCH3ectodomain and granular osmiophilic material in CADASIL", J Neuropathol Exp Neurol, 72, pp.416~431 (2013)
  97. Weller RO, "Lymphatic drainage of the brain and the pathophysiology of neurological disease", Acta Neuropathol, 117, pp.1~14 (2009)
  98. Yamamoto Y, "Neuropathological correlates of temporal pole white matter hyperintensities in CADASIL", Stroke, 40, pp.2004~2011 (2009)
  99. Aldea R, "Cerebrovascular smooth muscle cells as the drivers of intramural periarterial drainage of the brain", Front Aging Neurosci, 11, pp.1~ (2019)
  100. Schley D, "Mechanisms to explain the reverse perivascular transport of solutes out of the brain", J Theor Biol, 238, pp.962~974 (2006)
  101. Zellner A, "CADASIL brain vessels show a HTRA1 loss-of-function profile", Acta Neuropathol, 136, pp.111~125 (2018)
  102. Hara K, "Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease", N Engl J Med, 360, pp.1729~1739 (2009)
  103. Graham JR, "Serine protease HTRA1 antagonizes transforming growth factor-β signaling by cleaving its receptors and loss of HTRA1 in vivo enhances bone formation", PLoS One, 8, pp.e74094~ (2013)
  104. Shiga A, "Cerebral small-vessel disease protein HTRA1 controls the amount of TGF-β1 via cleavage of proTGF-β1", Hum Mol Genet, 20, pp.1800~1810 (2011)
  105. Shiga A, "Molecular pathogenesis of cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy", Brain Nerve, 62, pp.595~599 (2010)
  106. Kato T, "Excessive production of transforming growth factor β1 causes mural cell depletion from cerebral small vessels", Front Aging Neurosci, 12, pp.151~ (2020)
  107. An E, "Identification of novel substrates for the serine protease HTRA1 in the human RPE secretome", Invest Ophthalmol Vis Sci, 51, pp.3379~3386 (2010)
  108. Beaufort N, "Cerebral small vessel disease-related protease HtrA1 processes latent TGF-β binding protein 1 and facilitates TGF-β signaling", Proc Natl Acad Sci U S A, 111, pp.16496~16501 (2014)
  109. Panahi M, "Differences in proliferation rate between CADASIL and control vascular smooth muscle cells are related to increased TGFβ expression", J Cell Mol Med, 22, pp.3016~3024 (2018)
  110. Monet-Leprêtre M, "Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD : a new pathomechanism in CADASIL", Brain, 136(Pt 6), pp.1830~1845 (2013)
  111. Kast J, "Sequestration of latent TGF-β binding protein 1 into CADASIL-related Notch3-ECD deposits", Acta Neuropathol Commun, 2, pp.96~ (2014)
  112. Delaney CE, "The inhibitory effects of endostatin on endothelial cells are modulated by extracellular matrix", Exp Cell Res, 312, pp.2476~2489 (2006)
  113. Nagatoshi A, "Serum amyloid P component : a novel potential player in vessel degeneration in CADASIL", J Neurol Sci, 379, pp.69~76 (2017)
  114. Arboleda-Velasquez JF, "Hypomorphic Notch 3 alleles link Notch signaling to ischemic cerebral small-vessel disease", Proc Natl Acad Sci U S A, 108, pp.E128~E135 (2011)
  115. Yamamoto Y, "Disruption of transforming growth factor-βsuperfamily signaling : a shared mechanism underlying hereditary cerebral small vessel disease", Neurochem Int, 107, pp.211~218 (2017)
  116. Naba A, "The matrisome : in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices", Mol Cell Proteomics, 11 (2012)
  117. Mykkänen K, "Different clinical phenotypes in monozygotic CADASIL twins with a novel NOTCH3 mutation", Stroke, 40, pp.2215~2218 (2009)
  118. Liu X, "The genetic spectrum and the evaluation of CADASIL screening scale in Chinese patients with NOTCH3 mutations", J Neurol Sci, 354, pp.63~69 (2015)
  119. Singhal S, "The influence of genetic and cardiovascular risk factors on the CADASIL phenotype", Brain, 127(Pt 9), pp.2031~2038 (2004)
  120. Safar ME, "Interaction between hypertension and arterial stiffness", Hypertension, 72, pp.796~805 (2018)
  121. Rogers RL, "The effects of chronic cigarette smoking on cerebrovascular responsiveness to 5 per cent CO2 and 100 per cent O2 inhalation", J Am Geriatr Soc, 32, pp.415~420 (1984)
  122. Lacolley P, "Vascular smooth muscle cells and arterial stiffening : relevance in development, aging, and disease", Physiol Rev, 97, pp.1555~1617 (2017)
  123. Yoshiyama S, "Nicotine exposure alters human vascular smooth muscle cell phenotype from a contractile to a synthetic type", Atherosclerosis, 237, pp.464~470 (2014)
  124. Arribas SM, "Cellular changes induced by chronic nitric oxide inhibition in intact rat basilar arteries revealed by confocal microscopy", J Hypertens, 15(12 Pt 2), pp.1685~1693 (1997)
  125. Wardlaw JM, "Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration", Lancet Neurol, 12, pp.822~838 (2013)
  126. Chabriat H, "Patterns of MRI lesions in CADASIL", Neurology, 51, pp.452~457 (1998)
  127. van den Boom R, "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy : MR imaging findings at different ages--3rd-6th decades", Radiology, 229, pp.683~690 (2003)
  128. Kim Y, "Characteristics of CADASIL in Korea : a novel cysteine-sparing Notch3 mutation", Neurology, 66, pp.1511~1516 (2006)
  129. van Den Boom R, "Subcortical lacunar lesions : an MR imaging finding in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy", Radiology, 224, pp.791~796 (2002)
  130. Viswanathan A, "Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL", Neurology, 69, pp.172~179 (2007)
  131. Jouvent E, "Brain atrophy is related to lacunar lesions and tissue microstructural changes in CADASIL", Stroke, 38, pp.1786~1790 (2007)
  132. Fein G, "Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease", Neurology, 55, pp.1626~1635 (2000)
  133. Peters N, "Brain volume changes in CADASIL : a serial MRI study in pure subcortical ischemic vascular disease", Neurology, 66, pp.1517~1522 (2006)
  134. Jouvent E, "Prediction of 3-year clinical course in CADASIL", Neurology, 87, pp.1787~1795 (2016)
  135. Pescini F, "Circulating biomarkers in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy patients", J Stroke Cerebrovasc Dis, 26, pp.823~833 (2017)
  136. Marco Duering, "Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden", 대한뇌졸중영문학회지, 20(2), pp.228~238 (2018), 대한뇌졸중학회
  137. Gao D, "Changes in the morphology, number, and protein levels of plasma exosomes in CADASIL patients", J Alzheimers Dis, 81, pp.221~229 (2021)
  138. Petzold A, "Neurofilament phosphoforms : surrogate markers for axonal injury, degeneration and loss", J Neurol Sci, 233, pp.183~198 (2005)
  139. Teunissen CE, "Neurofilaments as biomarkers in multiple sclerosis", Mult Scler, 18, pp.552~556 (2012)
  140. Chen CH, "Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL", J Neuroinflammation, 17, pp.124~ (2020)
  141. Lu CH, "Neurofilament light chain : a prognostic biomarker in amyotrophic lateral sclerosis", Neurology, 84, pp.2247~2257 (2015)
  142. Bergman J, "Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS", Neurol Neuroimmunol Neuroinflamm, 3, pp.e271~ (2016)
  143. Machuca-Parra AI, "Therapeutic antibody targeting of Notch3 signaling prevents mural cell loss in CADASIL", J Exp Med, 214, pp.2271~2282 (2017)
  144. Muiño E, "Contribution of"omicΠstudies to the understanding of Cadasil. A systematic review", Int J Mol Sci, 22, pp.7357~ (2021)

관련 논문AI추천

Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: A Genetic Cause of Cerebral Small Vessel Disease최재철대한신경과학회 · Journal of Clinical Neurology2010 · 제6권 제1호Elderly CADASIL patients with intact neurological statusElisabeth Tournier-Lasserve, Elisa Ouin, Eric Jouvent, Hugues Chabriat, Jessica Lebenberg, Karine Ighilkrim, Lina Grosset, Ruiting Zhang, Stéphanie Guey, Véronique François대한뇌졸중학회 · 대한뇌졸중영문학회지2022 · 제24권 제3호Eighteen-Year Disease Progression and Survival in CADASILAnna M. van Opstal, Annemieke Aartsma-Rus, Bastian J. van Eijsden, Gido Gravesteijn, Huub A.M. Middelkoop, Jeroen van de Grond, Julie W. Rutten, Mar D.M. Rodriguez Girondo, Remco J. Hack, Saskia A.J. Lesnik Oberstein대한뇌졸중학회 · 대한뇌졸중영문학회지2021 · 제23권 제1호Phenotypic Features of Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Subjects with R544C Mutation오정환, 이정석, Ho Kyu Lee, Joon Hyuk Park, KeunHyuk Ko대한치매학회 · Dementia and Neurocognitive Disorders(대한치매학회지)2016 · 제15권 제1호Effects of Lacunar Infarctions on Cognitive Impairment in Patients with Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy강사윤, 강지훈, 나해리, 박지강, 이정석, 최재철대한신경과학회 · Journal of Clinical Neurology2011 · 제7권 제4호Possible Role of a Missense Mutation of p.P167S on NOTCH3 Gene Associated with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy김희진, 박성호, Byung Woo Choi대한치매학회 · Dementia and Neurocognitive Disorders(대한치매학회지)2016 · 제15권 제2호

이 간행물의 다른 논문 (13건)

Cerebro-/Cardiovascular Collateral Damage During the COVID-19 Pandemic: Fact or Fiction?Michail I Papafaklis, Lampros K Michalis, Theodoros Karapanayiotides, Georgios Tsivgoulis, Sotirios Giannopoulos, Christos S. Katsouraspp. 1-11Relationship Between MicroRNA Signature and Arterial Stiffness in Patients With Ischemic Stroke김정민, 박광열, 이상진, 이은선, 김혜련pp. 28-35Can Artificial Intelligence Diagnose Transient Global Amnesia Using Electroencephalography Data?이동아, 박강민, Young Deok Seopp. 36-43Electrophysiologic Characteristics of Nitrous-Oxide-Associated Peripheral Neuropathy: A Retrospective Study of 76 PatientsWeishuai Li, Miao Yu, Xiuying Fang, Han Gao, Dongming Zheng, Ying Mapp. 44-51Telbivudine-Induced Myopathy: Clinical Features, Histopathological Characteristics, and Risk FactorsChien-Hung Chen, Yung-Yee Chang, King-Wah Chiu, Tsu-Kung Lin, Shun-Sheng Chen, Min-Yu Lan, Hui-Chen Lin, Tsung-Hui Hu, Shu-Fang Chenpp. 52-59
원문 보기